Sharp Biomedical Closes Pre-Seed Funding

Sharp Biomedical, a medical device company, announced on Oct. 12, 2026, the successful closing of its pre-seed funding round led by gener8tor 1889. The capital will fund development of manual spinal care tools for outpatient clinics, aiming to democratize access without massive infrastructure costs.